ROIV - Roivant Sciences Ltd.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 11.39

Open

$ 11.48

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 11.30 - $ 11.49

52 Week Range

$ 8.06 - $ 13.24

Volume

3,693,343

Average Volume

Market Cap

9.62B

Beta (5Y Monthly)

$ 0.86

PE Ratio (TTM)

$ 2.08

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-13-2024	12-31-2023	10-Q
2	11-13-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	06-28-2023	03-31-2023	10-K
5	02-13-2023	12-31-2022	10-Q
6	11-14-2022	09-30-2022	10-Q
7	08-15-2022	06-30-2022	10-Q
8	06-28-2022	03-31-2022	10-K
9	02-14-2022	12-31-2021	10-Q
10	11-15-2021	09-30-2021	10-Q
11	09-21-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Roivant And Kinevant Sciences Complete Enr...
04/25/2024 12:08:24

Critical Insights From Roivant Sciences An...
04/22/2024 15:01:12

HC Wainwright & Co. Reiterates Buy on Roiv...
04/22/2024 10:34:04

HC Wainwright & Co. analyst Douglas Tsao reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $18 price ta...

Goldman Sachs Maintains Buy on Roivant Sci...
04/03/2024 15:18:11

Goldman Sachs analyst Corinne Jenkins maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $...

HC Wainwright & Co. Maintains Buy on Roiva...
04/03/2024 11:05:41

HC Wainwright & Co. analyst Douglas Tsao maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target...

Deutsche Bank Maintains Buy on Roivant Sci...
04/03/2024 09:14:44

Deutsche Bank analyst Neena Bitritto-Garg maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target fr...

vivek-ramaswamy-founded-roivants-anti-inflammatory-drug-aces-mid-stage-study

Vivek Ramaswamy-Founded Roivant's Anti-Inf...
04/02/2024 16:31:51

Roivant Sciences and Priovant Therapeutics report Phase 2 results for brepocitinib in treating non-anterior non-infectious uvei...

Roivant Sciences Reveals Board Authorizati...
04/02/2024 11:12:00

Sumitomo Pharma repurchase reduces shares outstanding by 9%

Roivant Announces Positive NEPTUNE Study R...
04/02/2024 11:10:22

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
03/29/2024 17:35:25

Roivant Sciences To Replace Sunrun In S&P ...
03/26/2024 21:20:46

Where Roivant Sciences Stands With Analysts
03/25/2024 17:00:27

Truist Securities Reiterates Buy on Roivan...
03/25/2024 16:14:34

Truist Securities analyst Robyn Karnauskas reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $23 price target.

5 Value Stocks In The Healthcare Sector
02/19/2024 14:42:59

Wolfe Research Initiates Coverage On Roiva...
02/15/2024 11:41:51

Wolfe Research analyst Andy Chen initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Outperform rating and announces...

The Analyst Landscape: 4 Takes On Roivant ...
02/14/2024 17:00:57

HC Wainwright & Co. Maintains Buy on Roiva...
02/14/2024 16:47:20

HC Wainwright & Co. analyst Douglas Tsao maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and lowers the price target...

Roivant Sciences Q3 2024 Adj EPS $(0.21) B...
02/13/2024 13:12:34

Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0....

Earnings Scheduled For February 13, 2024
02/13/2024 10:05:59

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on reven...

Roivant Sciences Earnings Preview
02/12/2024 16:01:11